Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
Blood|February 22, 2018
Neutrophils provide cellular communication between ileum and mesenteric lymph nodes at graft-versus-host disease onsetJan Hülsdünker, Katja J Ottmüller, Hannes P Neeff, et al.
Blood|July 2, 2011
Type I-IFNs control GVHD and GVL responses after transplantationRenee J Robb, Ellen Kreijveld, Rachel D Kuns, et al.
The New England Journal of Medicine|June 13, 2025
Graft-versus-Host Disease Prophylaxis with Cyclophosphamide and CyclosporinDavid J Curtis, Sushrut S Patil, John Reynolds, et al.
Blood|July 8, 2016
Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent mannerCameron McDonald-Hyman, Ryan Flynn, Angela Panoskaltsis-Mortari, et al.
JCI Insight|June 14, 2019
Chemotherapy followed by anti-CD137 mAb immunotherapy improves disease control in a mouse myeloma modelCamille Guillerey, Kyohei Nakamura, Andrea C Pichler, et al.
Blood|April 28, 2012
Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantationRenee J Robb, Katie E Lineburg, Rachel D Kuns, et al.
Blood|February 23, 2013
Promoting regulation via the inhibition of DNAM-1 after transplantationMotoko Koyama, Rachel D Kuns, Stuart D Olver, et al.
Blood|December 9, 2016
GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunityMark D Bunting, Antiopi Varelias, Fernando Souza-Fonseca-Guimaraes, et al.
Blood|January 29, 2021
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxisGlen A Kennedy, Siok-Keen Tey, Luke Buizen, et al.
Nature Communications|October 30, 2015
CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cellsErvin E Kara, Duncan R McKenzie, Cameron R Bastow, et al.
Pageof 22